Cancer

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in […]

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine bacterium Photobacterium angustum demonstrates remarkable […]

A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately predict whether the most common type of brain tumor will grow or cause symptoms, […]

Northwestern Medicine scientists have uncovered a surprising link between a tiny cellular engine and the way cancer cells build the DNA they need to proliferate, according to a new study published in Molecular Cell.This article […]

In many aspects of our lives, we find meaning in the order in which events occur. We buy into myths about “middle child syndrome,” talk of calm before storms, and consider it strange to start […]

A patented RNA-based cocktail developed at the Italian Institute of Technology (IIT-Istituto Italiano di Tecnologia) has emerged as a promising active agent against tumors of the central nervous system, such as glioblastoma.This article was originally […]

With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. Until now, all available treatments, including immunotherapy—which involves strengthening the immune system to fight cancer—have […]

Columbia University researchers are the first to show that focused ultrasound—a noninvasive technique that uses sound waves to enhance the delivery of drugs into the brain—can be safely used in children being treated for brain […]

Researchers at Peter Mac have discovered a new way to kill cancer cells in acute myeloid leukemia (AML), one of the most aggressive and hard to treat forms of blood cancer. The study is published […]

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms driving treatment resistance […]